首次使用环素联合治疗后与川崎病相关的关节炎:一个病例报告
Kaori Yoshida1, Yoshitaka Watanabe1, Maria Yoshimi1
1Children's Medical Center, Showa Medical University Northern Yokohama Hospital, Yokohama-shi, Japan.
Translational pediatrics
|September 15, 2025
概括
这一案例研究突出显示了卡瓦萨基病 (KD) 患有抗初始治疗的儿童的反应性关节炎. 患者需要循环氨酸A (CyA) 和因弗利克西马布 (IFX),发展关节问题,后来用类固醇治疗.
科学领域:
- 儿科 儿科 儿科
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
背景情况:
- 川崎病 (KD) 可能呈现治疗耐药性,需要先进的疗法.
- 反应性关节炎是KD的一个不常见的并发症,特别是在治疗耐药的情况下.
- 最近对KD治疗的指导方针进行了修订,影响了耐火病例的管理策略.
研究的目的:
- 报告与二次反应性关节炎相关的川崎病 (KD) 病例.
- 在患有KD的患者中描述治疗过程,包括环素A (CyA) 和infliximab (IFX).
- 强调在需要先进免疫抑制治疗的KD患者中对反应性关节炎的监测的重要性.
主要方法:
- 一个案例报告,一个5岁的男孩被诊断患有KD.
- 治疗涉及多次剂量的静脉注射免疫球蛋白 (IVIG),乌利纳斯塔丁,因弗力西马布 (IFX) 和环素A (CyA).
- 记录了使用普得尼索隆 (PSL) 治疗后续反应性关节炎的方法.
主要成果:
- 患者呈现KD和IVIG耐火性预测得分.
- 发烧随着包括CyA和IFX在内的联合治疗而消失.
- 发生了反应性关节炎,特征是关节疼痛,在PSL治疗后得到改善.
- 在治疗逐渐减少后,没有观察到关节症状或冠状动脉病变的复发.
结论:
- 环素A (CyA) 是对IVIG抗性川崎病 (KD) 的一个可行的选择.
- 临床医生必须对KD患者的二次反应性关节炎保持警,这些患者对初始治疗有耐药性,需要像Infliximab (IFX) 这样的疗法.
- 迅速识别和管理反应性关节炎对于KD患者的良好结果至关重要.
相关概念视频
01:21Rheumatic Heart Disease III: Medical Management
289
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
289
01:23Rheumatic Heart Disease I: Introduction
448
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
448
01:20Rheumatic Heart Disease IV: Nursing Management
276
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
276
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
500
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
500
01:17Pericarditis III: Medical Management
313
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
313
01:11Genome-wide Association Studies-GWAS
15.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.3K